نتائج البحث - "Stephen R. D. Johnston"

1

دورية أكاديمية

Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study

المؤلفون: Matthew P. Goetz, Irfan Cicin, Laura Testa, Sara M. Tolaney, Jens Huober, Valentina Guarneri, Stephen R. D. Johnston, Miguel Martin, Priya Rastogi, Nadia Harbeck, Ashwin Shahir, Ran Wei, Valérie André, Hope S. Rugo, Joyce O’Shaughnessy

المصدر: npj Breast Cancer, Vol 10, Iss 1, Pp 1-7 (2024)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2374-4677Test

الوصول الحر: https://doaj.org/article/1378a75d34cd4a89ad1255e30c08bb59Test

View record in DOAJ

النص الكامل

2

دورية أكاديمية

Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer

المؤلفون: Mark Pegram, Christian Jackisch, Stephen R. D. Johnston

المصدر: npj Breast Cancer, Vol 9, Iss 1, Pp 1-19 (2023)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2374-4677Test

الوصول الحر: https://doaj.org/article/680e57aefd68447cbc25c5d6d3fb71ceTest

View record in DOAJ

النص الكامل

3

دورية أكاديمية

Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2−, node-positive, high-risk early breast cancer

المؤلفون: Shani Paluch-Shimon, Patrick Neven, Jens Huober, Irfan Cicin, Matthew P. Goetz, Chikako Shimizu, Chiun-Sheng Huang, Hans Joachim Lueck, Jane Beith, Eriko Tokunaga, Jessica Reyes Contreras, Rosane Oliveira de Sant’Ana, Ran Wei, Ashwin Shahir, Sarah C. Nabinger, Tammy Forrester, Stephen R. D. Johnston, Nadia Harbeck

المصدر: Therapeutic Advances in Medical Oncology, Vol 15 (2023)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1758-8359Test

الوصول الحر: https://doaj.org/article/9dbf86693a4a460dbf6601907c6ba0edTest

View record in DOAJ

النص الكامل

4

دورية أكاديمية

Case Report: Neratinib Therapy Improves Glycemic Control in a Patient With Type 2 Diabetes and Breast Cancer

المؤلفون: Vasileios Angelis, Stephen R. D. Johnston, Amin Ardestani, Kathrin Maedler

المصدر: Frontiers in Endocrinology, Vol 13 (2022)

مصطلحات موضوعية: diabetes, neratinib, MST1, EGFR, HER2, breast cancer, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fendo.2022.830097/fullTest; https://doaj.org/toc/1664-2392Test

الوصول الحر: https://doaj.org/article/0c9dd3492760421480a43eb22fe8b545Test

View record in DOAJ

النص الكامل

5

Adjuvant CDK4/6 inhibitors: can they improve clinical outcomes in hormone receptor-positive (HR+) early breast cancer?

المؤلفون: Stephen R. D. Johnston

المصدر: Annals of Palliative Medicine. 12:421-426

مصطلحات موضوعية: Advanced and Specialized Nursing, Anesthesiology and Pain Medicine

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::474e18f19df74af32188f6525b7d7327Test
https://doi.org/10.21037/apm-22-981Test

6

Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer

المؤلفون: Stephen R D, Johnston

المصدر: Hematology/Oncology Clinics of North America. 37:89-102

مصطلحات موضوعية: Postmenopause, Oncology, Chemotherapy, Adjuvant, Humans, Female, Breast Neoplasms, Hematology, Prognosis, Combined Modality Therapy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05bd8e4378d29fc6f48e0b56673dc4adTest
https://doi.org/10.1016/j.hoc.2022.08.011Test

7

Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial

المصدر: The Lancet Oncology. 24:77-90

مصطلحات موضوعية: Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bff773b443545dc60195d174427ba206Test
https://doi.org/10.1016/s1470-2045Test(22)00694-5

8

A review on the added value of whole-body MRI in metastatic lobular breast cancer

المؤلفون: Basrull N. Bhaludin, Nina Tunariu, Dow-Mu Koh, Christina Messiou, Alicia F. Okines, Sophie E. McGrath, Alistair E. Ring, Marina M. Parton, Bhupinder Sharma, Tanja Gagliardi, Steven D. Allen, Romney Pope, Stephen R. D. Johnston, Kate Downey

المصدر: European Radiology. 32:6514-6525

مصطلحات موضوعية: Radiology, Nuclear Medicine and imaging, General Medicine

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3a7da00a1116c70dd3b1a506399b7be0Test
https://doi.org/10.1007/s00330-022-08714-6Test

9

Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Update

المؤلفون: Lindsay L. Peterson, Mark R. Somerfield, Larissa A. Korde, Harold J. Burstein, Rachel L. Yung, Dharamvir Jain, Stephen R. D. Johnston, Jennifer K. Litton, Debra L. Barton, Lesley Fallowfield, Praveen Vikas, Erin Macrae, Ali Dorris, Hope S. Rugo

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 39, iss 35
J Clin Oncol

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Receptor, ErbB-2, medicine.medical_treatment, Systemic therapy, Targeted therapy, ErbB-2, 0302 clinical medicine, Receptors, Molecular Targeted Therapy, skin and connective tissue diseases, Human Epidermal Growth Factor Receptor 2, Progesterone, Cancer, Tumor, Prognosis, Metastatic breast cancer, Receptors, Estrogen, Hormone receptor, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, ASCO Special Articles, Practice Guidelines as Topic, Female, Receptors, Progesterone, Receptor, medicine.medical_specialty, 2019-20 coronavirus outbreak, Antineoplastic Agents, Hormonal, Clinical Sciences, Oncology and Carcinogenesis, Breast Neoplasms, Antineoplastic Agents, 03 medical and health sciences, Clinical Research, Internal medicine, Breast Cancer, Biomarkers, Tumor, medicine, Humans, Endocrine system, Oncology & Carcinogenesis, neoplasms, Hormonal, business.industry, Evaluation of treatments and therapeutic interventions, Guideline, medicine.disease, Estrogen, 030104 developmental biology, business, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99e630d5df3b3a8bef6137fbb799786dTest
https://doi.org/10.1200/jco.21.01392Test

10

Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer – Authors' reply

المؤلفون: Stephen R D Johnston, Sara M Tolaney, Joyce O'Shaughnessy, Priya Rastogi, Nadia Harbeck, Miguel Martin

المصدر: The Lancet Oncology. 24:e238

مصطلحات موضوعية: Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4ebc2877999a9f938badb5c2c451c92bTest
https://doi.org/10.1016/s1470-2045Test(23)00214-0

تنقيح النتائج